Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $25.7 Million - $31.2 Million
97,800 Added 20.04%
585,800 $183 Million
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $6.96 Million - $8.41 Million
25,900 Added 5.6%
488,000 $139 Million
Q4 2023

Feb 14, 2024

SELL
$255.7 - $288.46 $80.4 Million - $90.7 Million
-314,300 Reduced 40.48%
462,100 $133 Million
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $34.9 Million - $41.2 Million
162,800 Added 26.53%
776,400 $172 Million
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $24.5 Million - $29.8 Million
108,400 Added 21.46%
613,600 $148 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $27.9 Million - $35.4 Million
121,700 Added 31.73%
505,200 $133 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $18.5 Million - $20.8 Million
82,200 Added 27.28%
383,500 $86.4 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $170B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.